Chaire de recherche du Canada en biologie cellulaire de la rétine
Investigating the regeneration and degeneration of blood vessels in eye disease.
This research will lead to understanding the mechanisms governing major causes of blinding diseases.
- Centre de recherche de l'Hôpital Maisonneuve-Rosemont
Other Institutions and Research Units
- CIUSSS de l'Est-de-l'Île-de-Montréal – Hôpital Maisonneuve-Rosemont (HMR)
For more information…
15-02-2016 Près de 30 M$ pour la recherche à l'Université de Montréal
14-11-2014 Deux médecins développent des médicaments expérimentaux pour les personnes atteintes de rétinopathie diabétique
29-09-2015 Félicitations à Mike Sapieha
Portraits de chercheurs / Mike Sapieha : faire le grand saut
20-07-2017 Mike Sapieha reçoit le prix de soutien Joe-Doupe à un chercheur débutant
30-09-2015 Mike Sapieha, lauréat du prix André-Dupont
03-04-2017 Mike Sapieha gagne le prix du jeune chercheur de l’ACN
At Université de Montreal
- Przemyslaw (Mike) Sapieha - Titulaire
Curbing Vision Loss and Eye Disease
In its various manifestations, ocular vaso-proliferative diseases such as proliferative diabetic retinopathy and neovascular age-related macular degeneration, account for the most common causes of vision loss in the industrial world. It is currently estimated that over 1 million Canadians suffer from various forms of age-related macular degeneration and 500,000 are afflicted by diabetic retinopathy. The incidence of both conditions is expected to double over the next 15 years, resulting in billions of dollars in medical costs and significant losses of productivity.
Dr. Przemyslaw (Mike) Sapieha, Canada Research Chair in Retinal Cell Biology, is investigating these and other common causes of vision loss in the industrial world. He is exploring how and why, in several eye diseases, blood vessels degenerate and subsequently try to compensate by creating new blood vessels in a disorganized fashion.
Sapieha is also focusing on increasing understanding of why in these blinding diseases, blood vessels fail to regenerate in one area of the affected retina yet invade other areas which are devoid of vasculature in healthy individuals.
Sapieha’s work will ultimately lead to the development of new treatment strategies that will improve the ability of the body to regenerate blood vessels to tackle prominent causes of vision loss.
Projects and funding
Publications and presentations
- Cell Biology
- Molecular Medicine